Stockton STK, a leading company in the development and marketing of botanical based solutions for crop protection, announced that its proprietary fungicide REGEV has received a product registration approval from Ministry of Agriculture in Guatemala.
REGEV is the first product of its kind formulated with a hybrid patented solution that delivers an effective long-lasting plant disease protection. The fungicide features two modes of action in one unique formulation, belonging to 2-different FRAC groups (Group 7 and G1). This new broad spectrum solution is based on the mixture of two active ingredients (AIs) in an easy-to-use solution that improves productivity, and efficiency of food production while reducing chemical load and the negative environmental impacts.
REGEV opens a new dimension in disease control enabling growers to protect plants from a wide range of plant diseases, including but not limited to: Powdery Mildews, Early Blight, Apple Scab, Alternaria, Cercospora and Cladosporium diseases in various fruit and vegetables, peanuts, coffee, rice, soybeans, cocoa, palm oil, ornamentals and others.
REGEV fast-acting protection solution is a valuable tool easily incorporated into resistance management programs and well-suited for use in integrated pest management (IPM) programs, providing an outstanding value per acre. When applied early in the season, REGEV’s long-lasting residual control helps to ensure crops are protected late into the season. If applied during the beginning of a disease, REGEV curative activity helps halt further disease development and protect yield potential.
“Guatemala is the first country in LATAM that marks the pathway where the product will be sold,” said Guy Elitzur, CEO of STK. “We are excited to offer growers in this region a curative and preventive easy-to-use formulation for the control and suppression of fungal and bacterial pathogens.”
REGEV is expected to be available for growers during 2017 in Argentina, Colombia, Dominican Republic, Honduras, Nicaragua, Panama, Peru, and Serbia. Other countries are in the registration process and will be available in the next coming year. It is available in a liquid concentrate (LC) formulation.